KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Cost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income - MinorityNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Newmont (NEM) Cost of Revenue (2016 - 2025)

Historic Cost of Revenue for Newmont (NEM) over the last 13 years, with Q3 2025 value amounting to $2.0 billion.

  • Newmont's Cost of Revenue fell 1554.11% to $2.0 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $8.4 billion, marking a year-over-year decrease of 480.0%. This contributed to the annual value of $9.0 billion for FY2024, which is 3379.61% up from last year.
  • As of Q3 2025, Newmont's Cost of Revenue stood at $2.0 billion, which was down 1554.11% from $2.0 billion recorded in Q2 2025.
  • Newmont's 5-year Cost of Revenue high stood at $2.4 billion for Q4 2024, and its period low was $6.0 million during Q2 2023.
  • In the last 5 years, Newmont's Cost of Revenue had a median value of $1.5 billion in 2022 and averaged $1.6 billion.
  • Its Cost of Revenue has fluctuated over the past 5 years, first tumbled by 9453.55% in 2022, then skyrocketed by 3583333.33% in 2024.
  • Quarter analysis of 5 years shows Newmont's Cost of Revenue stood at $1.5 billion in 2021, then rose by 15.58% to $1.8 billion in 2022, then increased by 29.38% to $2.3 billion in 2023, then rose by 3.82% to $2.4 billion in 2024, then dropped by 18.4% to $2.0 billion in 2025.
  • Its Cost of Revenue stands at $2.0 billion for Q3 2025, versus $2.0 billion for Q2 2025 and $2.1 billion for Q1 2025.